Table 1.
Participant demographic and baseline characteristics as a function of stimulant diagnosis and cigarette type
| Cocaine-Dependent | Methamphetamine-Dependent | |||||
|---|---|---|---|---|---|---|
| Non-Menthol N=100 |
Menthol N=201 |
Cigarette Analysisa |
Non-Menthol N=176 |
Menthol N=33 |
Cigarette Analysisa |
|
| Age (Years) | 39.5 (10.1) | 39.7 (9.8) | W=−0.3 | 33.1 (8.9) | 29.3 (6.5) | t (57.0)=2.8** |
| Sex (% Male) | 58.0% | 56.2% | X2(1)=0.1 | 48.3% | 30.3% | X2(1)=3.6 |
| Race (%) | F=0.0*** | F=0.0143 | ||||
| African-American | 15.2% | 74.6% | 2.3% | 3.0% | ||
| Caucasian | 76.8% | 22.4% | 82.4% | 93.9% | ||
| Other/mixed | 8.1% | 3.0% | 15.3% | 3.0% | ||
| Ethnicity (% Hispanic) | 18.0% | 4.0% | X2(1)=16.3*** | 18.2% | 12.1% | X2(1)=0.7 |
| Stimulant-positive UDSb | 20.0% | 38.3% | X2(1)=10.2** | 12.5% | 12.1% | F=0.2260 |
| Stimulant-use route (%) | F=0.002 | F=0.0005 | ||||
| Smoked | 59.0% | 66.2% | 60.8% | 57.6% | ||
| Nasal | 31.0% | 27.4% | 10.2% | 6.1% | ||
| IV | 7.0% | 4.0% | 27.3% | 24.2% | ||
| Other/no answer | 3.0% | 2.5% | 1.7% | 12.1% | ||
| Fagerström score | 5.6 (2.4) | 5.7 (2.2) | W=−0.2 | 5.6 (2.2) | 5.3 (2.2) | W=−0.5 |
| No. of Smoking years | 21.0 (9.6) | 22.8 (10.5) | W=−1.4 | 17.2 (8.7) | 12.3 (6.1) | t (58.9)=3.9** |
| No. of cigarettes/day | 17.5 (7.1) | 16.4 (7.9) | W=1.6 | 15.0 (7.3) | 16.5 (8.6) | W=1.1 |
Note:
a
W=Wilcoxon Rank Sum, t(df)=Student’s t, X2(df)=Chi-square, F=Fisher’s Exact;
b
UDS=Urine drug screen.
*
p < .05;
**
p < .01;
***
p <.001